Real-World Effectiveness of Dupilumab for Patients with Severe Asthma: A Retrospective Study.
Takanori NumataJun ArayaHanae MiyagawaKeitaro OkudaDaisuke TakekoshiMitsuo HashimotoShunsuke MinagawaTakeo IshikawaHiromichi HaraKazuyoshi KuwanoPublished in: Journal of asthma and allergy (2022)
Dupilumab treatment was useful for patients with SA in a real-world setting. However, the BEC should be monitored carefully, especially in patients who previously received anti-IL-5/IL-5 receptor antibody.
Keyphrases